Browsing by Author Parra-Guillen, Z.P. (Zinnia Patricia)
Showing results 1 to 7 of 7
| Issue Date | Title | Type | Author(s) |
| 2021 | A quantitative systems pharmacology model for acute viral hepatitis B | Articulo | Fernández-de-Trocóniz, J.I. (José Ignacio) ; Asín-Prieto, E. (Eduardo); Parra-Guillen, Z.P. (Zinnia Patricia); Gómez-Mantilla, J.D. (José David); Vandenbossche, J. (Joris); Stuyckens, K. (Kim); De-Trixhe, X. (Xavier); Pérez-Ruixo, J.J. (Juan José) |
| 13-Jan-2022 | Development of disease and drug models for rare diseases: Application to Acute Intermittent Porphyria. | Tesis | Vera-Yunca, D. (Diego) |
| 2020 | Disease pharmacokinetic–pharmacodynamic modelling in acute intermittent porphyria to support the development of mRNA-based therapies | Articulo | Fernández-de-Trocóniz, J.I. (José Ignacio); Parra-Guillen, Z.P. (Zinnia Patricia); Fontanellas-Romá, A. (Antonio); Jericó-Asenjo, D. (Daniel); Martini, P. (Paolo); Vera-Yunca, D. (Diego); Hard, M. (Marjie); Guey, L. T. (Lin); Jiang, L. (Lei) |
| 2012 | Kinetic and dynamic computational model-based characterization of new proteins in mice: application to interferon alpha linked to apolipoprotein a-I | Articulo | Parra-Guillen, Z.P. (Zinnia Patricia); Fioravanti, J. (Jessica); Medina-Echeverz, J. (José); Gomar, C. (Celia); Ardaiz, N. (Nuria); Troconiz, I.F. (Iñaki F.); Berraondo, P. (Pedro) |
| 2020 | Machine Learning Analysis of Individual Tumor Lesions in Four Metastatic Colorectal Cancer Clinical Studies: Linking Tumor Heterogeneity to Overall Survival | Articulo | Vera-Yunca, D. (Diego); Girard, P. (Pascal.); Parra-Guillen, Z.P. (Zinnia Patricia); Munafo, A. (Alain); Troconiz, I.F. (Iñaki F.); Terranova, N. (Nadia) |
| 2022 | Mechanistic modelling of enzyme-restoration effects of new recombinant liver-targeted proteins in acute intermittent porphyria | Articulo | Vera-Yunca, D. (Diego); Córdoba, K.M. (Karol M.); Parra-Guillen, Z.P. (Zinnia Patricia); Jericó-Asenjo, D. (Daniel); Fontanellas-Romá, A. (Antonio); Troconiz, I.F. (Iñaki F.) |
| 2019 | Model-Informed Dose Selection for Xentuzumab, a Dual Insulin-Like Growth Factor-I/II—Neutralizing Antibody | Articulo | Fernández-de-Trocóniz, J.I. (José Ignacio); Parra-Guillen, Z.P. (Zinnia Patricia); Schmid, U. (Ulrike); Janda, A. (Álvaro); Freiwald, M. (Matthias) |
